Michel Detheux has sold ITOS and made no open-market buys since Jun 2021
CEO at Iteos Therapeutics, Inc.
SEC CIK 0001816196 · Filings on SEC.gov ↗
$0Bought
$7.4MSold
NoneLast buy
Every filing
13 filings since Jun 2021, newest first
ITOSSell
Iteos Therapeutics, Inc.
CEO
$367K−30.0%Apr 19
ITOSSell
Iteos Therapeutics, Inc.
CEO
$630K−41.0%Mar 22
ITOSSell
Iteos Therapeutics, Inc.
CEO
$498K−29.0%Feb 24
ITOSSell
Iteos Therapeutics, Inc.
CEO
$517K−23.0%Jan 26
ITOSSell
Iteos Therapeutics, Inc.
CEO
$2.0M−41.0%Dec 22
ITOSSell
Iteos Therapeutics, Inc.
CEO
$523K−16.0%Nov 24
ITOSSell
Iteos Therapeutics, Inc.
CEO
$587K−21.0%Nov 3
ITOSSell
Iteos Therapeutics, Inc.
CEO
$51K−2.0%Oct 19
ITOSSell
Iteos Therapeutics, Inc.
CEO
$180K−6.0%Sep 27
ITOSSell
Iteos Therapeutics, Inc.
CEO
$581K−16.0%Sep 3
ITOSSell
Iteos Therapeutics, Inc.
CEO
$412K−10.0%Aug 31
ITOSSell
Iteos Therapeutics, Inc.
CEO
$241K−6.0%Aug 25
ITOSSell
Iteos Therapeutics, Inc.
CEO
$827K−16.0%Jun 16
Filings come from SEC EDGAR. Not investment advice.